Skip to main content
FDA issues proposed rule on de novo classification
12/5/2018

The FDA has released the De Novo Classification Proposed Rule to clarify and streamline its de novo pathway by outlining processes and criteria for reviewing novel low- to moderate-risk devices. The rule, which is open to public comment, is expected to encourage greater use of the pathway.

Full Story: